Moran Wealth Management’s ALPS Medical Breakthroughs ETF SBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.11M Buy
36,110
+2,080
+6% +$136K 0.06% 315
2026
Q2
$2.2M Buy
34,030
+4,682
+16% +$257K 0.06% 310
2026
Q1
$1.54M Buy
29,348
+8,264
+39% +$420K 0.05% 331
2025
Q4
$1.08M Buy
21,084
+3,897
+23% +$180K 0.03% 351
2025
Q3
$668K Buy
17,187
+7,206
+72% +$248K 0.02% 376
2025
Q2
$300K Buy
+9,981
New +$285K 0.01% 453

Other funds holding SBIO

Moran Wealth Management's SBIO Position: Q3 2026 in Review

Moran Wealth Management increased its ALPS Medical Breakthroughs ETF (SBIO) stake by 6.1% in Q3 2026, buying an estimated $136K and bringing the position to 36,110 shares worth $2.11M. The position accounts for 0.06% of the portfolio, ranked #315.

Moran Wealth Management first reported a position in SBIO in Q2 2025 and has held it in 6 quarters since. The position peaked at $2.2M in Q2 2026. 77 funds tracked by Wall St. Rank hold SBIO as of Q3 2026.

  • Moran Wealth Management held 36,110 shares of ALPS Medical Breakthroughs ETF worth $2.11M as of Q3 2026.
  • Moran Wealth Management bought 2,080 ALPS Medical Breakthroughs ETF shares in Q3 2026, an estimated $136K.
  • ALPS Medical Breakthroughs ETF made up 0.06% of Moran Wealth Management's portfolio in Q3 2026, its #315 holding.
  • Moran Wealth Management first reported a position in ALPS Medical Breakthroughs ETF in Q2 2025 and has held it in 6 quarters since.
  • Moran Wealth Management's ALPS Medical Breakthroughs ETF position peaked at $2.2M in Q2 2026.
  • 77 funds tracked by Wall St. Rank held ALPS Medical Breakthroughs ETF as of Q3 2026.

Based on Moran Wealth Management's 13F filing for Q3 2026, filed 22 Oct 2026.